Skip to main content

SYSTEMATIC REVIEW article

Front. Nutr.
Sec. Nutrition and Metabolism
Volume 11 - 2024 | doi: 10.3389/fnut.2024.1380962

Wild Thyme (Thymus serpyllum L.): A Review of the Current Evidence of Nutritional and Preventive Health Benefits Provisionally Accepted

 Banaz Jalil1*  Ivo Pischel1, 2* Björn Feistel3  Cynthia Suarez3* Andressa Blainski3  Ralf Spreemann3 René Roth-Ehrang3  Michael Heinrich1, 4*
  • 11Pharmacognosy and Phytotherapy, UCL School of Pharmacy, United Kingdom
  • 24Dr. Ivo Pischel Consulting, Germany
  • 33Finzelberg GmbH & Co.KG,, Germany
  • 42Chinese Medicine Research Center, Department of Pharmaceutical Sciences and Chinese Medicine Resources, College of Chinese Medicine, China Medical University, Taiwan

The final, formatted version of the article will be published soon.

Receive an email when it is updated
You just subscribed to receive the final version of the article

Thymus serpyllum L. (Lamiaceae), known in English as 'wild thyme', is primarily found in the Palearctic realm (Eurasia, North Africa) and has been utilised traditionally for culinary, nutritional, medicinal, and aromatic purposes. The essential oil extracted from wild thyme is particularly noteworthy, being used extensively in the food industry as a flavouring agent and preservative. The plant's aerial parts are commonly employed as an element of the diet (e.g., tea)/for culinary uses and in local/traditional medicine (primarily for managing respiratory and gastrointestinal conditions), similar to the use of common thyme.There is practically no information available on the species' nutritional benefits. Pharmacological studies, including in vitro and in vivo research, alongside a limited number of clinical trials, have investigated extracts of Thymus serpyllum, although these extracts are often phytochemically poorly characterised in different experimental protocols and models. These studies have demonstrated a range of therapeutic effects, such as antimicrobial (notably the essential oil) and anti-inflammatory, as well as its preventative health benefits and nutritional value of wild thyme. Preclinical studies have corroborated the plant's anti-inflammatory potential, particularly in conditions like inflammatory bowel diseases (IBD) and irritable bowel syndromes (IBS). Additionally, evidence of hepatoprotective activities and benefits in managing metabolic syndrome and cardiovascular health issues, such as lipid metabolism regulation, cholesterol reduction, antidiabetic, antihypertensive, and immunomodulatory effects, have been observed predominantly in rodent models.Phytochemical analysis of wild thyme reveals an essential oil fraction below 1%, along with non-volatile compounds predominantly comprising phenolic acids (such as rosmarinic, salvianolic, and caffeic acids) and flavonoids (mainly glucosides of luteolin, apigenin, and their derivatives). These components are believed to contribute significantly to the plant's medicinal, nutritional, and preventive health properties. Despite promising findings, there is a need for more rigorously designed controlled clinical trials using phytochemically characterised wild thyme. The plant has an excellent safety and tolerability record. This review at the interface of nutritional/preventive health properties and as pharmacological activities highlights the current role of wild thyme in nutrition and general healthcare as well as its future potential, and also points to important gaps in the literature.

Keywords: Wild thyme, Thymus serpyllum, nutrition, HEALTH PREVENTION, Phytopharmacology, Traditional use, Gut-brain interaction, Rosmarinic acid

Received: 02 Feb 2024; Accepted: 11 Apr 2024.

Copyright: © 2024 Jalil, Pischel, Feistel, Suarez, Blainski, Spreemann, Roth-Ehrang and Heinrich. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Dr. Banaz Jalil, 1Pharmacognosy and Phytotherapy, UCL School of Pharmacy, London, United Kingdom
Dr. Ivo Pischel, 1Pharmacognosy and Phytotherapy, UCL School of Pharmacy, London, United Kingdom
Dr. Cynthia Suarez, 3Finzelberg GmbH & Co.KG,, Andernach, Germany
Prof. Michael Heinrich, 1Pharmacognosy and Phytotherapy, UCL School of Pharmacy, London, United Kingdom